Asymptomatic microscopic hematuria - Is investigation necessary?

Journal of Clinical Epidemiology

Volumn 50, Issue 11, 1997, Pages 1197-1200

  Froom, Paul ^a,c   Froom, Jack ^b   Ribak, Joseph ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b STONY BROOK UNIVERSITY   (United States)

^c Occupational Health and Rehabilitation Institute Israel   (Israel)

Author keywords

Asymptomatic disease; Microscopic hematuria; Screening

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEMATURIA; HUMAN; MASS SCREENING; PATIENT SELECTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; URINALYSIS;

ADULT; FEMALE UROGENITAL DISEASES; HEMATURIA; HUMANS; MALE UROGENITAL DISEASES; MASS SCREENING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 0030727269     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00124-8     Document Type: Article

References (39)

1. Freni SC, Henderik GJ, Hol C. Centrifugation techniques and reagent strips in the assessment of microhaematuria. J Clin Pathol 1977; 30: 336-340.
2. Froom P, Ribak J, Benbassat J. Significance of microhaematuria in young adults. Br Med J 1984; 288: 20-22.
3. Whelan P, Britton JP, Dowell AC. Three-year follow-up of bladder tumours found on screening. Br J Urol 1993; 72: 893-896.
4. Lynch TH, Waymont B, Dunn JA, Hughes MA, Wallace DMA. Rapid diagnostic service for patients with haematuria. Br J Urol 1994; 73: 147-151.
5. Davides KC, King LM, Jacobs D. Management of microscopic hematuria: Twenty-year experience with 150 cases in a community hospital. Urology 1986; 28: 453-455.
6. Gillatt DA, O'Reilly PH. Haematuria analysed-A prospective study. J Royal Soc Med 1987; 80: 559-560.
7. Thompson IM. The evaluation of microscopic hematuria: A population based study. J Urol 1987; 138: 1189-1190.
8. Carson CC, Segura JW, Green LF. Clinical importance of microhematuria J Am Med Assoc 1979; 241: 149-150.
9. Greene LF, O'Shaughnessy EJ, Hendricks ED. Study of five hundred patients with asymptomatic microhematuria. J Am Med Assoc 1956; 161: 610-613.
10. Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk benefit and cost-effectiveness analysis. J Urol 1989; 141: 350-355.
11. Sutton JM. Evaluation of hematuria in adults. J Am Med Assoc 1990; 263: 2475-2480.
12. Firfer R. Clinical importance of microhematuria. J Am Med Assoc 1979; 241: 165-166.
13. Cadman D, Chambers LW, Feldmen WR, Sackett DL. Assessing the effectiveness of community screening programs. J Am Med Assoc 1984; 251: 1580-1585.
14. Shimazui T, Kasaya T, Imada S. Bladder tumors detected by transabdominal ultrasonography. Nippon-Hinyokika-Gakkai-Zasshi 1992; 83: 1847-1851.
15. Bee DE, Gordon JP, Paul KL. Hemoglobinuria and hematuria: Accuracy and precision of laboratory diagnosis. Clin Chem 1979; 25: 1696-1699.
16. Gadeholt H. Quantitative estimation of urinary sediment with special regard to sources of error. Br Med J 1964; i: 1547-1550.
17. Messing EM, Young TB, Hunt VB, Emoto SE, Wehbie JM. The significance of asymptomatic microhematuria in men 50 or more years old: Findings of a home screening study using urinary dipsticks. J Urol 1987; 137: 919-925.
18. Offringa M, Benbassat J. The value of urinary red cell shape in the diagnosis of glomerular and post-glomerular haematuria. A meta-analysis. Postgrad Med J 1992; 68: 648-654.
19. Kitamoto Y, Tomita M, Akamine M, Inoue T, Itoh J, Takamori H, Sato T. Differentiation of hematuria using a uniquely shaped red cell. Nephron 1993; 64: 32-36.
20. Mohr DN, Offord KP, Melton LJ. Isolated asymptomatic microhematuria: A cross-sectional ayalysis of test-positive and test-negative patients. J Gen Intern Med 1987; 2: 318-374.
21. Britton JP, Dowell AC, Whelan P. Dipstick haematuria and bladder cancer in men over 60: Results of a community study. Br Med J 1989; 299: 1010-1012.
22. Schroder FH. Microscopic haematuria; requires investigation. Br Med J 1994; 309: 70-72.
23. Richie JP. Intravesical chemotherapy: Treatment selection, techniques and results. Urol Clin NA 1992; 19: 521-527.
24. Levi F, La Vecchia C, Randimbison L, Franceschi S. Incidence of infiltrative cancer following superficial bladder carcinoma. Int J Cancer 1993; 55: 419-421.
25. Ghersi D, Steward LA, Parmar MKB, Coppin C, Martinez-Pineiro J, Raghavan D, Wallace MA. Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: A meta-analysis of individual patient data from randomized clinical trials. Br J Urol 1995; 75: 206-213.
26. Aso Y, Homma Y. A survey on incidental renal cell carcinoma in Japan. J Urol 1992; 147: 340-343.
27. Ozen H, Colowick A, Freiha FS. Incidentally discovered solid renal masses: What are they? Br J Urol 1993; 72: 274-276.
28. Waters WB, Richie JP. Aggressive surgical approach to renal cell carcinoma. Review of 130 cases. J Urol 1979; 306-309.
29. Pardo V, Berian MG, Levi D, Strauss J. Benign primary hematuria. clinicopathologic study of 65 patients. Am J Med 1979; 67: 817-822.
30. Ibels LS, Gyory AZ. IgA Nephropathy: Analysis of the natural history, important factors in the progression of renal disease and a review of the literature. Medicine 1994; 73: 79-102.
31. Copley JB, Hasbargen JA. Idiopathic hematuria. Arch Intern Med 1987; 147: 434-437.
32. Topham PS, Harper SJ, Furness PN, Karris KPG, Walls J, Feehally J. Glomerular disease as a cause of isolated microscopic haematuria. Quart J Med 1994; 87: 329-335.
33. Feld LG, Stapleton FB, Duffy L. Renal biopsy in children with asymptomatic hematuria or proteinuria: Survey of pediatric nephrologists. Pediatr Nephrol 1993; 7: 441-443.
34. Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994; 23: 247-254.
35. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994; 331: 1194-1199.
36. Galla JH. IgA nephropathy. Kidney Int 1995; 47: 377-387.
37. Sox HC. Preventive health services in adults. N Engl J Med 1994; 330: 1589-1595.
38. Gartman E. The significance of hematuria in young men. J Urol 1956; 75: 135-142.
39. Bard RH. The significance of asymptomatic microhematuria in women and its economic implications. Arch Intern Med 1988; 148: 2629-2632.